PPERFORMS shines at the Cambridge Conference on Breast Cancer Imaging 2024.
At the Cambridge Conference on Breast Cancer Imaging 2024 (September 10-11), PERFORMS played a key role in showcasing its impact on breast screening and artificial intelligence (AI). Oral and poster presentations included:
Breast human and AI evaluation “Performance in Screening”
- “Using PERFORMS to tune the recall threshold for breast cancer detection artificial intelligence (AI) algorithms”
- “Does PERFORMS help improve breast screening reader performance?”
Professor Yan Chen and the team emphasised the importance of PERFORMS in evaluating and monitoring AI performance, particularly with frequent updates in AI software. Each update introduces new features but requires rigorous testing to ensure consistent or improved performance in crucial areas like cancer detection. Ongoing assessment with PERFORMS helps maintain the reliability of AI systems, ensuring they meet high standards for accurate breast screening.
As AI continues to evolve, tools like PERFORMS will be critical for monitoring AI performance, enabling safe integration into clinical practice while maintaining diagnostic accuracy in breast cancer screenings.
